Artificial Intelligence to Measure Adherence to Oral Medication

Recruiting now · Phase 4

Conditions studied: First Episode Psychosis

In brief

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

Key facts

Study ID

NCT04046497

Run by

Northwell Health

People needed

200

Starts

2020-11-20

Expected to finish

2024-12-31

Last updated by the study team

2024-09-19

Who can join

Age: 15 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrolled in a CSC program
• Prescribed an oral antipsychotic

You may not qualify if…

• none

Where it is running

• Citrus Health — Hialeah, Florida, United States (enrolling)
• InterAct — Grand Rapids, Michigan, United States (enrolling)
• InterAct of Michigan — Kalamazoo, Michigan, United States (enrolling)
• Red Rock — Oklahoma City, Oklahoma, United States (enrolling)
• Family and Children's Services — Tulsa, Oklahoma, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.